ChosenMed Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
ChosenMed General Information
Description
Manufacturer of precision oncology diagnostic kits designed to enable accurate tumour detection and personalised cancer treatment. The company offers multi-gene companion diagnostic assays, tumor gene testing panels and early cancer screening products across solid tumors and hematologic malignancies, enabling hospitals, oncology laboratories and cancer specialists, to conduct precise molecular diagnostics and guide targeted therapeutic decisions.
Contact Information
Website
www.chosenmedtech.comCorporate Office
- Number 156, Jinghai Fourth Road, Beijing Economic and Technological Development Area
- Donghu Street, Linping District, Hangzhou City, Jinghai Industrial Park
- Beijing, Zhejiang 100176
- China
Corporate Office
- Number 156, Jinghai Fourth Road, Beijing Economic and Technological Development Area
- Donghu Street, Linping District, Hangzhou City, Jinghai Industrial Park
- Beijing, Zhejiang 100176
- China
ChosenMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 24-Oct-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 22-Mar-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C2) | 20-Dec-2021 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 17-Dec-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C1) | 08-Oct-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 27-Jul-2020 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 15-Mar-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 15-Mar-2020 | Completed | Product In Beta Test | |||
| 2. Early Stage VC | 14-May-2018 | Completed | Product In Beta Test | |||
| 1. Early Stage VC (Series A) | 18-Mar-2018 | Completed | Product In Beta Test |
ChosenMed Signals
ChosenMed Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gandao Investment Holding Company | Asset Manager | Minority | ||
| Dezhou Financial Investment | Growth/Expansion | Minority | ||
| Hangzhou Linzhuo Industry Investment | Government | Minority | ||
| Hunan High-Tech Investment Group | Venture Capital | Minority | ||
| Jingming Innovation Capital | Venture Capital | Minority |
ChosenMed Investments (1)
ChosenMed’s most recent deal was a Seed Round with Xinchuan Biotechnology for . The deal was made on 28-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Xinchuan Biotechnology | 28-Mar-2022 | Seed Round | Drug Discovery |
ChosenMed FAQs
-
When was ChosenMed founded?
ChosenMed was founded in 2017.
-
Where is ChosenMed headquartered?
ChosenMed is headquartered in Beijing, China.
-
What is the size of ChosenMed?
ChosenMed has 17 total employees.
-
What industry is ChosenMed in?
ChosenMed’s primary industry is Diagnostic Equipment.
-
Is ChosenMed a private or public company?
ChosenMed is a Private company.
-
What is ChosenMed’s current revenue?
The current revenue for ChosenMed is .
-
How much funding has ChosenMed raised over time?
ChosenMed has raised $78M.
-
Who are ChosenMed’s investors?
Gandao Investment Holding Company, Dezhou Financial Investment, Hangzhou Linzhuo Industry Investment, Hunan High-Tech Investment Group, and Jingming Innovation Capital are 5 of 14 investors who have invested in ChosenMed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process